Navigation Links
Nile Therapeutics Completes Dosing of Phase II Study
Date:7/7/2010

patient visit to occur at the end of July. Final results from the study are expected in the fourth quarter of 2010.

"We are extremely pleased to announce the completion of enrollment for this study and look forward to being able to discuss our data later this year," said Joshua A. Kazam, Nile's CEO. "We believe that CD-NP has the potential to be an exciting new therapy that provides unique clinical benefit to patients with cardiovascular and renal disease.  Our next steps in the development of CD-NP as therapy for acute heart failure are to finalize the design of a double-blind, placebo controlled Phase IIb study and to discuss that trial design with the FDA and other regulatory authorities.  We look forward to those discussions and to the continued advancement of the CD-NP program."

About Nile Therapeutics

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs. Nile is initially focusing its efforts on developing its lead compound, CD-NP, a novel, rationally designed chimeric peptide in clinical studies for the treatment of heart failure, and CU-NP, a second novel, rationally designed natriuretic peptide. More information on Nile can be found at http://www.nilethera.com.

Safe Harbor Paragraph for Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of his
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... MADISON HEIGHTS, Mich. , May 5, 2015 /PRNewswire/ ... provider of infusion pumps and related services for the ... first quarter financial results on Tuesday, May 12, 2015 ... also conduct a conference call for investors on Tuesday, ... discuss first quarter performance and results.  To participate in ...
(Date:5/5/2015)... Mass., May 5, 2015   Cynosure, Inc. ... medical devices for aesthetic procedures and precision surgical applications ... ended March 31, 2015. First-Quarter Highlights: ... , Non-GAAP earnings of $0.15 per share; GAAP ... million at March 31, 2015 "Cynosure delivered ...
(Date:5/5/2015)... 5, 2015  Omron Healthcare, Inc., the leader in home ... blood pressure monitor and scale with connectivity via smartphone, tablet, ... With the ... rise, remote patient monitoring has become increasingly important for not ... "These easy to ...
Breaking Medicine Technology:Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 2Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 3Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 4Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 5Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 6Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 7Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 8Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 9Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 10Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 11New Blood Pressure Monitor And Scale Allow Chronically Ill Patients To Stay At Home While Connected To Healthcare Professionals 2New Blood Pressure Monitor And Scale Allow Chronically Ill Patients To Stay At Home While Connected To Healthcare Professionals 3
(Date:5/5/2015)... The global lab automation market is expected to ... 2014, at an estimated CAGR of 6.7% from 2015 ... on the basis of equipment and software, application, type ... of application, Lab Automation Market is classified into clinical ... discovery is a major application of the lab automation ...
(Date:5/5/2015)... New York, NY (PRWEB) May 05, 2015 The ... based on the experiences of Dr. Brad Reedy from ... When Judith Regan was asked why she chose to publish a ... me as a parent (and publisher) is the idea that it ... question...that we and our children are on the trek sometimes together ...
(Date:5/5/2015)... 2015 Skedans Systems a ... announced the Skedans Sensor Collaboration Platform at AUVSI's ... web app developers, provides tooling to deliver real time ... , The Skedans Sensor Collaboration Platform is a single ... Internet of Things, Web Real Time Communications (WebRTC), and ...
(Date:5/5/2015)... Information Innovators Inc. (“Triple-i”), ... government, today announced its acquisition of Creative ... exclusively to federal government customers through its highly ... health services, and program management support. The company ... a Third Party Assessment Organization (3PAO) for cloud ...
(Date:5/5/2015)... SC (PRWEB) May 05, 2015 On May, ... episode with Charleston musician Irene Rose about alternatives for youngsters ... Rose, “How did you get the idea for starting a ... replies, “I run an entertainment company called Once Upon a ... them moral lessons through songs and even scripture. We play ...
Breaking Medicine News(10 mins):Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2
... exposed as a drug addict with suicidal tendencies by his ... Kaylee feels that her grandfather would be heartbroken if he ... Gable, now. , ,She said: "My father is dying ... were alive today it would break his heart to see ...
... things and accepts them, although medical transcription is not so popular ... papers and are not well stocked in most cases. It is ... ,In contrast, in the US, medical case files are dictated by ... the US is well established. It is more than two decades ...
... Clinical Endocrinologists (AACE) Fifteenth Annual Meeting and Clinical Congress ... April 26-30 will discuss important benefits //of vitamin D ... ,Vitamin D has been in the ... disease has been attributed to it. Recent studies have ...
... features of the heart muscle could be used to ... is linked to a lethal, inherited heart condition // ... of Mayo’s HCM Clinic and co-lead investigator of the ... test was only able to detect this quirk about ...
... Brachytherapy, which is touted as the best and latest ... Sydney's Mater Hospital Radiotherpahy Department.// ,It is ... set to improve results with fewer side effects. ... the southern hemisphere, bringing together image-enhancing technology that builds ...
... Seattle scientists are planning to study the Major Histocompatibility Complex ... method for doing the same.// MHC is a large region, ... genes, the HLA genes governs tissue type and participate in ... governing susceptibility to autoimmune diseases or cancer. The MHC is ...
Cached Medicine News:Health News:Rising in career top charts is Medical transcription 2Health News:Unraveling the Secrets of MHC in Human Genome 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: